Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$109.52 - $120.96 $925,663 - $1.02 Million
-8,452 Reduced 98.95%
90 $10,000
Q4 2023

Feb 12, 2024

BUY
$90.19 - $110.4 $734,326 - $898,876
8,142 Added 2035.5%
8,542 $940,000
Q3 2023

Nov 02, 2023

BUY
$95.53 - $114.62 $382 - $458
4 Added 1.01%
400 $38,000
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $30,838 - $34,360
306 Added 340.0%
396 $43,000
Q1 2023

May 03, 2023

BUY
$96.86 - $114.01 $8,039 - $9,462
83 Added 1185.71%
90 $9,000
Q4 2022

Feb 03, 2023

BUY
$95.06 - $111.52 $665 - $780
7 New
7 $0
Q2 2022

Jul 18, 2022

BUY
$102.07 - $123.37 $4,286 - $5,181
42 New
42 $5,000
Q1 2022

Apr 25, 2022

SELL
$114.02 - $139.04 $5,016 - $6,117
-44 Closed
0 $0
Q4 2021

Jan 21, 2022

BUY
$115.53 - $141.46 $5,083 - $6,224
44 New
44 $6,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $229B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Tfo Tdc, LLC Portfolio

Follow Tfo Tdc, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfo Tdc, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tfo Tdc, LLC with notifications on news.